原文开头
A SINGLE drug has been found to inhibit a range of common viruses in lab studies, including coronaviruses, respiratory syncytial virus (RSV), norovirus, and influenza and hepatitis viruses. It will be tested in a clinical trial next year, raising hopes that the pill could one day be taken at home to relieve unpleasant symptoms. By mining data from old papers and patents, the AI named ERA-923 as a potential candidate that could bind to the Thumb-1 domain and thus block viral replication. “As far as we can tell, this is the first drug that’s ever demonstrated activity across all these viral families,” says Daniel Haders, co-founder of Model Medicines, the California- based company leading its development. …
摘自《新科学家》(New Scientist)第3590期 · 2026年4月11日,Alice Klein。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。